The following article is about a new study that suggests a novel treatment -- a form of estrogen, called estriol -- may reduce MS symptoms.
MS is thought to be of higher prevalence among veterans of the 1991 Gulf War, but a lack of clear data continues to leave certainty of that belief unclear.
A 2008 law mandated the U.S. Department of Veterans Affairs (VA) contract with the Institute of Medicine, part of the National Academy of Sciences, to determine the prevalence of MS and other neurological diseases in veterans of the 1991 Gulf War, the Iraq War, and the Afghanistan War. To date, VA has failed to implement the law.
Among the many provisions in legislation passed unanimously last week by the U.S. House of Representatives, the Gulf War Health Research Reform Act (H.R. 4261), is a "sense of Congress" that VA must abide by this neurological disease prevalence study and numerous other specifically enumerated health research-related laws that VA staff have to date failed to implement.
SOURCE: NPR (Jon Hamilton reporting), June 2, 2014